eSource has long been touted as the solution to high data management and monitoring costs and inefficiencies. This webinar will cover the history of eSource, the reasons it did not take off as quickly as people initially expected, and where eSource is headed. From EMR/EHR to wearables, to site source, the industry is moving towards capturing data electronically for clinical trials and then repurposing it for downstream analysis, at a far higher volume than usual due to COVID-19.
eSource has the potential to change the antiquated process of capturing data during a clinical trial. The effect on the efficiency of monitoring, site and data management processes is significant. Join this webinar to hear first-hand how one CRO leveraged eSource to lower overall costs for sites, data management and monitoring.
This webinar will provide a grounding in what eSource is, how it can be deployed, the practical implementation of eSource and how to avoid hurdles in the process.
Stephen Boccardo, SVP Business Development, and Commercial Strategy, Quartesian
As SVP business development and commercial strategy, Stephen Boccardo handles all aspects of customer business development. He combines more than 30 years of life science industry experience and dedicated technology expertise with a record of success on the clinical data management and systems side as well as growing startup organizations through sales and marketing leadership. Mr. Boccardo joined Quartesian from Clinical Ink where he served as Chief Commercial Officer. In this role, he was responsible for all Clinical Ink global sales and marketing activities to drive market adoption of the company’s industry-leading eSource products and solutions.Message Presenter
Lisa Charlton, PhD, MBA, Product Manager of Participant Engagement, ePro and eConsent, Medrio
Lisa Charlton brings a wealth of clinical research and business experience to her role as Customer Success Manager at Medrio. With an extensive background in structural biology, she has worked as contributing investigator and author of nine peer-reviewed publications and helped earn a patent for a biomedical device. She has also spent six years in the eClinical industry, supporting and consulting for clinical outcome assessments as well as assisting with eCOA implementation and design. Lisa holds a Ph.D. in Biological Chemistry from the University of North Carolina at Chapel Hill and an MBA from Point Park University, Pittsburgh.Message Presenter
Who Should Attend?
- Clinical Data Management Professionals
- Clinical Operations Professionals
- Clinical IT Professionals
- Clinical Innovation Professionals
- Clinical Research Professionals
- Medical Affairs Professionals
What You Will Learn
- Learn what eSource is, how it works and how it applies to a decentralized or virtual trial environment
- Discover why eSource is being more widely adopted as a result of COVID-19, and how it relates to patient safety
- Learn how to implement eSource and overcome obstacles in the process
Medrio is the leading provider of eClinical technology for early-phase pharma, device, and diagnostics clinical trials. Founded in 2005, the company’s cloud-based EDC, eSource, eConsent, and ePRO solutions deliver fast, flexible, and easy-to-use tools for the collection and management of clinical data and patient reported outcome responses. Study sponsors and contract research organizations have used Medrio extensively in clinical trials across a wide array of therapeutic areas, with notable success in oncology, infectious disease, and more. Medrio has extensive experience in all study phases and leads the market in early-phase trials. The company serves over 500 customers globally, with headquarters in San Francisco and offices in numerous domestic and international locations. For more information, please visit www.medrio.com.